This is the first time researchers have mapped genetic risk for hemochromatosis, sometimes called the ‘Celtic curse’, across the UK and Ireland. The condition has long been known to affect Scottish and Irish populations at higher rates, but until now its geographic distribution had not been clearly charted.

Experts say the findings could help health officials focus genetic screening in the areas most affected, allowing people at risk to be identified earlier and treated before serious complications develop.

Iron Overload Can Damage Organs Over Decades

Hemochromatosis often develops slowly. Excess iron can accumulate in organs for years or even decades before symptoms appear. If left untreated, it can lead to liver damage, liver cancer, arthritis, and other serious health problems. Early diagnosis makes a major difference. Regular blood donation to lower iron levels is a simple and effective treatment that can prevent much of the harm.

The disease is caused by inherited changes in DNA known as genetic variants. In the UK and Ireland, the main risk factor is a variant called C282Y.

Researchers at the University of Edinburgh analyzed genetic information from more than 400,000 people who took part in the UK BioBank and Viking Genes studies. They examined how common the C282Y variant was in 29 regions across the British Isles and Ireland.

Where the C282Y Gene Variant Is Most Common

The highest rates were found among people with ancestry from north west Ireland, where about one in 54 people are estimated to carry the variant. The Outer Hebrides followed closely at one in 62, and Northern Ireland at one in 71.

Mainland Scotland also showed elevated risk, particularly in Glasgow and southwest Scotland. In those areas, about one in 117 people carry the variant, reinforcing the long standing ‘Celtic Curse’ nickname.

Because the combined genetic risk is so high in these regions, researchers say targeted screening there would likely identify the greatest number of people with the condition.

Diagnosis Patterns and Possible Under Detection

The team also reviewed NHS England records and found more than 70,000 diagnosed cases of hemochromatosis. White Irish individuals were nearly four times more likely to be diagnosed than white British individuals.

Among white British individuals, those living in Liverpool were 11 times more likely to have a diagnosis than people in Kent. Researchers suggest this may reflect historical Irish migration, as more than 20 percent of Liverpool’s population was Irish in the 1850s.

In general, diagnosis rates in England mirror the pattern of genetic risk. However, Birmingham, Cumbria, Northumberland and Durham reported fewer cases than expected based on their genetic profiles. These areas may have undetected cases and could benefit from expanded screening efforts.

Comparable NHS prevalence data were not available for Scotland, Wales and Northern Ireland, so those regions were not included in that portion of the analysis.

The study was funded by the charity Haemochromatosis-UK and conducted in partnership with RCSI University of Medicine and Health Sciences. It was published in Nature Communications.

Calls for Community Wide Genetic Screening

Professor Jim Flett Wilson, Chair of Human Genetics at the University of Edinburgh, said: “If untreated, the iron-overload disease hemochromatosis can lead to liver cancer, arthritis and other poor outcomes. We have shown that the risk in the Hebrides and Northern Ireland is much higher than previously thought, with about one in every 60 people at risk, about half of whom will develop the disease. Early detection prevents most of the adverse consequences and a simple treatment — giving blood — is available. The time has come to plan for community-wide genetic screening in these high-risk areas, to identify as many people as possible whose genes mean they are at high risk of this preventable illness.”

Jonathan Jelley MBE JP, CEO of Haemochromatosis UK, said: “Although there are other forms and genotypes that can lead to iron overload, available research indicates C282Y presents as the greatest risk. This hugely important work has the potential to lead to greater targeted awareness, increased diagnosis and better treatment pathways for thousands of people affected by genetic hemochromatosis.

“As a charity we have already begun work on targeting and prioritizing hotspot areas of the UK for support including with our National Helpline and clinician education. Using this study we will continue to campaign for better allocation of public resources to this preventable condition that is all too often overlooked.”

Torcuil Crichton, the Labour MP for Na h-Eileanan an Iar (the Western Isles), has hemochromatosis and backs the push for screening in the Western Isles.

Torcuil Crichton MP said: “This research writes the case for community-wide screening in the Western Isles, Northern Ireland, and other hemochromatosis hotspots. I have previously raised this with Ministers in the House of Commons and this new evidence ought to be enough to persuade the UK National Screening Committee to review its position and approve a pilot screening program. The Western Isles offers a contained and distinct population sample to start from.

“Early identification, which I was lucky to have, means a whole range of bad health outcomes can be avoided and I’ll be urging Ministers and the Screening Committee to reconsider their stance.”

Scientists at Gladstone Institutes now say they have identified the reason. Their research shows that in low oxygen environments, red blood cells begin absorbing large amounts of glucose from the bloodstream. In effect, the cells act like sugar sponges under conditions similar to those found on the world’s tallest mountains.

In findings published in Cell Metabolism, the team demonstrated that red blood cells can alter their metabolism when oxygen levels drop. This shift allows the cells to deliver oxygen to tissues more efficiently at high altitude. At the same time, it lowers circulating blood sugar, offering a potential explanation for reduced diabetes risk.

According to senior author Isha Jain, PhD, a Gladstone Investigator, core investigator at Arc Institute, and professor of biochemistry at UC San Francisco, the study resolves a longstanding question in physiology.

“Red blood cells represent a hidden compartment of glucose metabolism that has not been appreciated until now,” Jain says. “This discovery could open up entirely new ways to think about controlling blood sugar.”

Red Blood Cells Identified as a Glucose Sink

Jain’s lab has spent years studying hypoxia, the term for reduced oxygen levels in the blood, and its effects on metabolism. In earlier experiments, her team noticed that mice exposed to low oxygen air had dramatically lower blood glucose levels. The animals rapidly cleared sugar from their bloodstream after eating, which is typically linked to lower diabetes risk. However, when researchers examined major organs to determine where the glucose was being used, they found no clear answer.

“When we gave sugar to the mice in hypoxia, it disappeared from their bloodstream almost instantly,” says Yolanda Martí-Mateos, PhD, a postdoctoral scholar in Jain’s lab and first author of the new study. “We looked at muscle, brain, liver — all the usual suspects — but nothing in these organs could explain what was happening.”

Using a different imaging method, the researchers discovered that red blood cells were serving as the missing “glucose sink,” meaning they were taking in and using significant amounts of glucose from circulation. This was unexpected because red blood cells have traditionally been viewed as simple oxygen carriers.

Follow up experiments in mice confirmed the finding. Under low oxygen conditions, the animals produced more red blood cells overall, and each individual cell absorbed more glucose compared with cells formed under normal oxygen levels.

To uncover the molecular details behind this shift, Jain’s group partnered with Angelo D’Alessandro, PhD, of the University of Colorado Anschutz Medical Campus, and Allan Doctor, MD, from University of Maryland, who has long studied red blood cell biology.

Their work showed that when oxygen is limited, red blood cells use glucose to generate a molecule that helps release oxygen to tissues. This process becomes especially important when oxygen is in short supply.

“What surprised me most was the magnitude of the effect,” D’Alessandro says. “Red blood cells are usually thought of as passive oxygen carriers. Yet, we found that they can account for a substantial fraction of whole-body glucose consumption, especially under hypoxia.”

Implications for Diabetes Treatment

The researchers also found that the metabolic benefits of prolonged hypoxia lasted for weeks to months after mice were returned to normal oxygen levels.

They then evaluated HypoxyStat, a drug recently developed in Jain’s lab that mimics low oxygen exposure. HypoxyStat is taken as a pill and works by causing hemoglobin in red blood cells to bind oxygen more tightly, limiting the amount delivered to tissues. In mouse models of diabetes, the medication completely reversed high blood sugar and outperformed existing treatments.

“This is one of the first use of HypoxyStat beyond mitochondrial disease,” Jain says. “It opens the door to thinking about diabetes treatment in a fundamentally different way — by recruiting red blood cells as glucose sinks.”

The findings may also apply beyond diabetes. D’Alessandro notes potential relevance for exercise physiology and for pathological hypoxia after traumatic injury. Trauma remains a leading cause of death among younger people, and changes in red blood cell production and metabolism could affect glucose availability and muscle performance.

“This is just the beginning,” Jain says. “There’s still so much to learn about how the whole body adapts to changes in oxygen, and how we could leverage these mechanisms to treat a range of conditions.”

Study Details and Funding

The study, titled “Red Blood Cells Serve as a Primary Glucose Sink to Improve Glucose Tolerance at Altitude,” appeared in Cell Metabolism on February 19, 2026. The authors include Yolanda Martí-Mateos, Ayush D. Midha, Will R. Flanigan, Tej Joshi, Helen Huynh, Brandon R. Desousa, Skyler Y. Blume, Alan H. Baik, and Isha Jain of Gladstone; Zohreh Safari, Stephen Rogers, and Allan Doctor of University of Maryland; and Shaun Bevers, Aaron V. Issaian, and Angelo D’Alessandro of University of Colorado Anschutz.

Funding was provided by the National Institutes of Health (DP5 DP5OD026398, R01 HL161071, R01 HL173540, R01HL146442, R01HL149714, DP5OD026398), the California Institute for Regenerative Medicine, Dave Wentz, the Hillblom Foundation, and the W.M. Keck Foundation.

Earlier research found that ultramarathon runners often experience a breakdown of healthy red blood cells during races, which can potentially lead to anemia. However, scientists have not fully understood why this happens. The new study found that after prolonged races, red blood cells become less flexible. Because these cells must bend to pass through tiny blood vessels while delivering oxygen and removing waste, reduced flexibility may limit their efficiency. The team also created the most detailed molecular profile to date showing how endurance races alter red blood cells.

“Participating in events like these can cause general inflammation in the body and damage red blood cells,” said the study’s lead author, Travis Nemkov, PhD, associate professor in the department of biochemistry and molecular genetics at the University of Colorado Anschutz. “Based on these data, we don’t have guidance as to whether people should or should not participate in these types of events; what we can say is, when they do, that persistent stress is damaging the most abundant cell in the body.”

Inside the Study of Ultramarathon Runners

To examine these effects, researchers measured indicators of red blood cell health before and after athletes competed in two demanding races: the Martigny-Combes à Chamonix race (40 kilometers or about 25 miles long) and the Ultra Trail de Mont Blanc race (171 kilometers or 106 miles long). Red blood cells are responsible for carrying oxygen and transporting waste products throughout the body, and their ability to flex is critical for moving through narrow blood vessels.

The team collected blood samples from 23 runners immediately before and after their races. They analyzed thousands of proteins, lipids, metabolites, and trace elements in both plasma and red blood cells. The results consistently showed signs of injury driven by both mechanical (physical) and molecular factors. Mechanical stress likely resulted from shifts in fluid pressure as blood circulates during intense running. Molecular damage appeared linked to inflammation and oxidative stress (when the body has low levels of antioxidants, which fight off molecules that damage DNA and other components within cells).

Longer Races, Greater Cellular Stress

Evidence of accelerated aging and increased breakdown of red blood cells was visible after the 40 kilometer race and was even more pronounced among athletes who completed the 171 kilometer event. Based on these findings, researchers suggest that longer races may lead to greater loss of red blood cells and more damage to those that remain in circulation.

“At some point between marathon and ultra-marathon distances, the damage really starts to take hold,” said Dr. Nemkov. “We’ve observed this damage happening, but we don’t know how long it takes for the body to repair that damage, if that damage has a long-term impact, and whether that impact is good or bad.”

Implications for Performance and Blood Storage

With additional research, the team believes these findings could help guide personalized training, nutrition, and recovery strategies aimed at improving performance while limiting potential harm from extreme endurance exercise. The work may also have broader medical relevance. Stored blood used for transfusions begins to deteriorate after several weeks and must be discarded after six weeks under U.S. Food and Drug Administration regulations. Understanding how intense physical stress affects red blood cells could provide insight into improving blood storage practices.

“Red blood cells are remarkably resilient, but they are also exquisitely sensitive to mechanical and oxidative stress,” said study co-author, Angelo D’Alessandro, PhD, professor at the University of Colorado Anschutz and member of the Hall of Fame of the Association for the Advancement of Blood and Biotherapies. “This study shows that extreme endurance exercise pushes red blood cells toward accelerated aging through mechanisms that mirror what we observe during blood storage. Understanding these shared pathways gives us a unique opportunity to learn how to better protect blood cell function both in athletes and in transfusion medicine.”

Study Limitations and Future Research

The research included a small group of participants and lacked racial diversity. Blood samples were also collected at only two time points. The investigators plan to expand future studies to include more participants, additional blood samples, and more detailed measurements after races. They also intend to further explore ways to extend the shelf life of stored blood.

To compare performance directly, researchers assigned identical tasks to different groups. Some teams relied entirely on human expertise, while others used scientists working with AI tools. The challenge was to predict preterm birth using data from more than 1,000 pregnant women.

Even a junior research pair made up of a UCSF master’s student, Reuben Sarwal, and a high school student, Victor Tarca, successfully developed prediction models with AI support. The system generated functioning computer code in minutes — something that would normally take experienced programmers several hours or even days.

The advantage came from AI’s ability to write analytical code based on short but highly specific prompts. Not every system performed well. Only 4 of the 8 AI chatbots produced usable code. Still, those that succeeded did not require large teams of specialists to guide them.

Because of this speed, the junior researchers were able to complete their experiments, verify their findings, and submit their results to a journal within a few months.

“These AI tools could relieve one of the biggest bottlenecks in data science: building our analysis pipelines,” said Marina Sirota, PhD, a professor of Pediatrics who is the interim director of the Bakar Computational Health Sciences Institute (BCHSI) at UCSF and the principal investigator of the March of Dimes Prematurity Research Center at UCSF. “The speed-up couldn’t come sooner for patients who need help now.”

Sirota is co-senior author of the study, published in Cell Reports Medicine on Feb. 17.

Why Preterm Birth Research Matters

Speeding up data analysis could improve diagnostic tools for preterm birth — the leading cause of newborn death and a major contributor to long term motor and cognitive challenges in children. In the United States, roughly 1,000 babies are born prematurely each day.

Researchers still do not fully understand what causes preterm birth. To investigate possible risk factors, Sirota’s team compiled microbiome data from about 1,200 pregnant women whose outcomes were tracked across nine separate studies.

“This kind of work is only possible with open data sharing, pooling the experiences of many women and the expertise of many researchers,” said Tomiko T. Oskotsky MD, co-director of the March of Dimes Preterm Birth Data Repository, associate professor in UCSF BCHSI, and co-author of the paper.

However, analyzing such a vast and complex dataset proved challenging. To tackle this, the researchers turned to a global crowdsourcing competition called DREAM (Dialogue on Reverse Engineering Assessment and Methods).

Sirota co-led one of three DREAM pregnancy challenges, focusing specifically on vaginal microbiome data. More than 100 teams worldwide participated, developing machine learning models designed to detect patterns linked to preterm birth. Most groups completed their work within the three month competition window. Yet it took nearly two years to consolidate the findings and publish them.

Testing AI on Pregnancy and Microbiome Data

Curious whether generative AI could shorten that timeline, Sirota’s group partnered with researchers led by Adi L. Tarca, PhD, co-senior author and professor in the Center for Molecular Medicine and Genetics at Wayne State University in Detroit, MI. Tarca had led the other two DREAM challenges, which focused on improving methods for estimating pregnancy stage.

Together, the researchers instructed eight AI systems to independently generate algorithms using the same datasets from the three DREAM challenges, without direct human coding.

The AI chatbots received carefully written natural language instructions. Much like ChatGPT, the systems were guided through detailed prompts designed to steer them toward analyzing the health data in ways comparable to the original DREAM participants.

Their objectives mirrored the earlier challenges. The AI systems analyzed vaginal microbiome data to identify signs of preterm birth and examined blood or placental samples to estimate gestational age. Pregnancy dating is almost always an estimate, yet it determines the type of care women receive as pregnancies progress. When estimates are inaccurate, preparing for labor becomes more difficult.

Researchers then ran the AI generated code using the DREAM datasets. Only 4 of the 8 tools produced models that matched the performance of the human teams, although in some cases the AI models performed better. The entire generative AI effort — from inception to submission of a paper — took just six months.

Scientists emphasize that AI still requires careful oversight. These systems can produce misleading results, and human expertise remains essential. However, by rapidly sorting through massive health datasets, generative AI may allow researchers to spend less time troubleshooting code and more time interpreting results and asking meaningful scientific questions.

“Thanks to generative AI, researchers with a limited background in data science won’t always need to form wide collaborations or spend hours debugging code,” Tarca said. “They can focus on answering the right biomedical questions.”

Authors: UCSF authors are Reuben Sarwal; Claire Dubin; Sanchita Bhattacharya, MS; and Atul Butte, MD, PhD. Other authors are Victor Tarca (Huron High School, Ann Arbor, MI); Nikolas Kalavros and Gustavo Stolovitzky, PhD (New York University); Gaurav Bhatti (Wayne State University); and Roberto Romero, MD, D(Med)Sc (National Institute of Child Health and Human Development (NICHD)).

Funding: This work was funded by the March of Dimes Prematurity Research Center at UCSF, and by ImmPort. The data used in this study was generated in part with support from the Pregnancy Research Branch of the NICHD.

The research zeroed in on polymer binders used in the negative electrodes of lithium-ion batteries (anodes). These binders act like a glue that holds the electrode materials together. Even though they account for less than 5% of the electrode’s total weight, they strongly influence mechanical strength, electrical and ionic conductivity, and how long a battery can operate through repeated charge cycles.

Because binders are present in such small amounts and lack clear visual signatures, scientists have had difficulty determining exactly where they are located within the electrode. This has limited efforts to fine tune battery performance, since the way binders are distributed directly affects conductivity, structural stability, and long term durability.

Patent Pending Staining Technique Reveals Hidden Structure

To overcome this obstacle, the researchers designed a patent-pending staining approach that attaches traceable silver and bromine markers to widely used cellulose- and latex-based binders in graphite- and silicon-based anodes. Once labeled, the binders can be detected because they emit characteristic X-rays (measured with energy-dispersive X-ray spectroscopy) or reflect high-energy electrons from the sample surface (measured with energy-selective backscattered electron imaging).

When viewed under an electron microscope, these signals provide detailed maps of where specific elements are located and what the electrode surface looks like. This allows scientists to analyze binder distribution with far greater precision than before.

Lead author Dr. Stanislaw Zankowski (Department of Materials, University of Oxford) said: “This staining technique opens up an entirely new toolbox for understanding how modern binders behave during electrode manufacturing. For the first time, we can accurately see the distribution of these binders not only generally (i.e., their thickness throughout the electrode), but also locally, as nanoscale binder layers and clusters, and correlate them with anode performance.”

The method works with standard graphite electrodes as well as advanced materials such as silicon or SiOx, making it relevant for both current lithium-ion batteries and next-generation designs.

Faster Charging and Longer Battery Life

By applying the new imaging tool, the team discovered that even subtle shifts in binder distribution can significantly change how efficiently a battery charges and how long it lasts. In testing, adjustments to slurry mixing and drying steps reduced the internal ionic resistance of experimental electrodes by as much as 40% — a major barrier to fast charging.

The researchers also captured detailed images of extremely thin layers of carboxymethyl cellulose (CMC) binder that coat graphite particles. The technique enabled clear detection of CMC layers just 10 nm thick and visualized structures spanning four orders of magnitude within a single image. The images revealed that what begins as a uniform CMC coating can break apart into uneven, patchy fragments during electrode processing, which may weaken battery performance and stability.

Co-author Professor Patrick Grant (Department of Materials, University of Oxford) said: “This multidisciplinary effort-spanning chemistry, electron microscopy, electrochemical testing, and modelling- has resulted in an innovative imaging approach that will help us to understand key surface processes that affect battery longevity and performance. This will drive forward advancements across a wide range of battery applications.”

The work was supported by the Faraday Institution’s Nextrode project and has already drawn significant interest from industry, including major battery producers and electric vehicle manufacturers.

Alzheimer’s is the most common type of dementia and affects roughly 57 million people worldwide. Scientists have long recognized air pollution as a risk factor for Alzheimer’s, as well as for chronic conditions such as hypertension, stroke, and depression. Because these conditions are also tied to dementia, researchers have questioned whether polluted air raises Alzheimer’s risk indirectly by contributing to those illnesses, or whether it harms the brain more directly. Another possibility was that existing health problems could make the brain more sensitive to pollution.

Large Medicare Study of 27.8 Million Older Adults

To explore these questions, the Emory team analyzed data from more than 27.8 million U.S. Medicare beneficiaries age 65 and older between 2000 and 2018. They compared levels of air pollution exposure with new cases of Alzheimer’s disease, while carefully considering the presence of other chronic health conditions.

The analysis revealed that people exposed to higher levels of air pollution had a greater likelihood of developing Alzheimer’s. The relationship was somewhat stronger among individuals who had previously suffered a stroke. In contrast, hypertension and depression did not meaningfully increase the pollution related risk.

Direct Brain Effects of Fine Particulate Pollution

Taken together, the results indicate that air pollution may raise Alzheimer’s risk mainly through direct effects on the brain rather than by triggering other chronic diseases. At the same time, a history of stroke appears to increase vulnerability, suggesting that certain individuals face compounded risks.

The findings also point to cleaner air as a potential strategy for lowering dementia rates and protecting cognitive health in aging populations.

The authors add, “In this large national study of older adults, we found that long-term exposure to fine particulate air pollution was associated with a higher risk of Alzheimer’s disease, largely through direct effects on the brain rather than through common chronic conditions such as hypertension, stroke, or depression.”

“Our findings suggest that individuals with a history of stroke may be particularly vulnerable to the harmful effects of air pollution on brain health, highlighting an important intersection between environmental and vascular risk factors.”

This work was supported by the National Institutes of Health (R01 AG074357 to KS and R01 ES034175 to YL).

Researchers at The University of Texas at Austin now report evidence that may resolve that puzzle. Writing in the journal Nature, the team focused on a group of microbes called Asgard archaea, which are considered close relatives of the ancestors of complex life. Although most known Asgards live in deep-sea or other oxygen-poor environments, the new study shows that some members of this group can tolerate or even use oxygen. The discovery strengthens the long-standing theory that complex life evolved as predicted, likely in an environment where oxygen was present.

“Most Asgards alive today have been found in environments without oxygen,” explained Brett Baker an associate professor of marine science and integrative biology at UT. “But it turns out that the ones most closely related to eukaryotes live in places with oxygen, such as shallow coastal sediments and floating in the water column, and they have a lot of metabolic pathways that use oxygen. That suggests that our eukaryotic ancestor likely had these processes, too.”

The Great Oxidation Event and Early Eukaryotes

Baker’s team studies the genomes of Asgard archaea to identify new branches of the group and better understand how these microbes generate energy. Their latest findings align with what geologists and paleontologists have reconstructed about Earth’s early atmosphere.

More than 1.7 billion years ago, oxygen levels in the atmosphere were extremely low. Then oxygen concentrations rose sharply during what scientists call the Great Oxidation Event, eventually approaching levels similar to those today. Within a few hundred thousand years of this dramatic increase, the earliest known microfossils of eukaryotes appear in the fossil record. This close timing suggests that oxygen may have played a crucial role in the emergence of complex life.

“The fact that some of the Asgards, which are our ancestors, were able to use oxygen fits in with this very well,” Baker said. “Oxygen appeared in the environment, and Asgards adapted to that. They found an energetic advantage to using oxygen, and then they evolved into eukaryotes.”

Symbiosis and the Birth of Mitochondria

The prevailing model holds that eukaryotes arose when an Asgard archaeon formed a symbiotic relationship with an alphaproteobacterium. Over time, the two organisms became integrated into a single cell. The alphaproteobacterium eventually evolved into the mitochondria, the structure inside eukaryotic cells that produces energy.

In this study, researchers significantly expanded the known genetic diversity of Asgard archaea. They identified specific groups, including Heimdallarchaeia, that are especially closely related to eukaryotes but are relatively uncommon today.

“These Asgard archaea are often missed by low-coverage sequencing,” said co-author Kathryn Appler, a postdoctoral researcher at the Institut Pasteur in Paris, France. “The massive sequencing effort and layering of sequence and structural methods enabled us to see patterns that were not visible prior to this genomic expansion.”

Massive Genome Sequencing Effort

The work began with Appler’s Ph.D. research at The University of Texas Marine Science Institute in 2019, when she extracted DNA from marine sediments. The UT team and collaborators ultimately assembled more than 13,000 new microbial genomes. The project combined samples from multiple marine expeditions and required analyzing roughly 15 terabytes of environmental DNA.

From this extensive dataset, the researchers recovered hundreds of new Asgard genomes, nearly doubling the known genomic diversity of the group. By comparing genetic similarities and differences, they built an expanded Asgard archaea tree of life. The newly identified genomes also revealed previously unknown protein groups, doubling the number of recognized enzymatic classes within these microbes.

AI Analysis of Oxygen Metabolism Proteins

The team then examined Heimdallarchaeia more closely, comparing their proteins to those found in eukaryotes that are involved in energy production and oxygen metabolism. To do this, they used an artificial intelligence system called AlphaFold2 to predict the three-dimensional shapes of the proteins. Because a protein’s structure determines how it functions, this analysis provided important clues.

The results showed that several Heimdallarchaeia proteins closely resemble those used by eukaryotic cells for oxygen-based, energy-efficient metabolism. This structural similarity offers additional support for the idea that the ancestors of complex life were already adapted to using oxygen.

Other contributors to the study included former UT researchers Xianzhe Gong (currently at Shandong University in China), Pedro Leão (now at Radboud University in the Netherlands), Marguerite Langwig (now at the University of Wisconsin-Madison) and Valerie De Anda (currently at the University of Vienna). James Lingford and Chris Greening at Monash University in Australia, along with Kassiani Panagiotou and Thijs Ettema at Wageningen University in the Netherlands, also participated in the research.

Funding was provided in part by the Gordon and Betty Moore and Simons Foundations, the National Natural Science Foundation of China and the National Health and Medical Research Council of Australia.